Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284653
Max Phase: Preclinical
Molecular Formula: C32H37F6N7O7S2
Molecular Weight: 546.72
Associated Items:
ID: ALA5284653
Max Phase: Preclinical
Molecular Formula: C32H37F6N7O7S2
Molecular Weight: 546.72
Associated Items:
Canonical SMILES: C[n+]1nn(-c2ccc(-c3nc(CCc4ccccc4)cs3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F
Standard InChI: InChI=1S/C29H35N7O2S.C2HF3O2.CHF3O3S/c1-34-25(9-5-6-14-30)20-36(33-34)24-12-13-26(27(19-24)38-18-17-35-16-15-31-29(35)37)28-32-23(21-39-28)11-10-22-7-3-2-4-8-22;3-2(4,5)1(6)7;2-1(3,4)8(5,6)7/h2-4,7-8,12-13,19-21H,5-6,9-11,14-18,30H2,1H3;(H,6,7);(H,5,6,7)
Standard InChI Key: CDRHMFVWJYVLGL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 546.72 | Molecular Weight (Monoisotopic): 546.2646 | AlogP: 3.29 | #Rotatable Bonds: 13 |
Polar Surface Area: 102.18 | Molecular Species: BASE | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.39 | CX Basic pKa: 10.20 | CX LogP: 0.79 | CX LogD: -1.82 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.20 | Np Likeness Score: -1.09 |
1. de Lucio H, Revuelto A, Carriles AA, de Castro S, García-González S, García-Soriano JC, Alcón-Calderón M, Sánchez-Murcia PA, Hermoso JA, Gago F, Camarasa MJ, Jiménez-Ruiz A, Velázquez S.. (2022) Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity., 244 [PMID:36332553] [10.1016/j.ejmech.2022.114878] |
Source(1):